Neurofilament is an autoantigenic determinant in myasthenia gravis

Annals of Neurology

Volumn 46, Issue 2, 1999, Pages 167-175

  Schultz, Anja ^a   Hoffacker, Viola ^a   Wilisch, Annette ^a   Nix, Wilfried ^b   Gold, Ralf ^a   Schalke, Berthold ^c   Tzartos, Socrates ^d   Müller Hermelink, Hans Konrad ^a   Marx, Alexander ^a,e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d HELLENIC PASTEUR INSTITUTE   (Greece)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CHOLINERGIC RECEPTOR; EPITOPE; NEUROFILAMENT PROTEIN; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MYASTHENIA GRAVIS; NEUROFILAMENT; PARANEOPLASTIC SYNDROME; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THYMOMA; THYMUS HYPERPLASIA;

EID: 0032864615     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199908)46:2<167::AID-ANA5>3.0.CO;2-3     Document Type: Article

References (32)

1. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330: 1797-1810
2. Oosterhuis HJ, Kuks JB. Myasthenia gravis and myasthenic syndromes. Curr Opin Neurol Neurosurg 1992;5:638-644
3. Marx A, Wilisch A, Schultz A, et al. Pathogenesis of myasthenia gravis. Virchows Arch 1997;430:355-364
4. Müller-Hermelink HK, Marx A, Kirchner T. Advances in the diagnosis and classification of thymic epithelial tumors. In: Anthony P, MacSween R, eds. Recent advances in histopathology. Edinburgh: Churchill Livingstone, 1994:49-63
5. Kirchner T, Tzartos S, Hoppe F, et al. Pathogenesis of myasthenia gravis: acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am J Pathol 1988;130:268-280
6. Siara J, Rudel R, Marx A. Absence of acetylcholine-induced current in epithelial cells from thymus glands and thymomas of myasthenia gravis patients. Neurology 1991;41:128-131
7. Geuder KI, Marx A, Witzemann V, et al. Genomic organization and lack of transcription of the nicotinic acetylcholine receptor subunit genes in myasthenia gravis-associated thymoma. Lab Invest 1992;66:452-458
8. Cikes N, Momoi MY, Williams CL, et al. Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow. Mayo Clin Proc 1988;63:474-481
9. Marx A, Kirchner T, Greiner A, et al. Neurofilament epitopes in chymoma and antiaxonal autoantibodies in myasthenia gravis. Lancet 1992;339:707-708
10. Marx A, O'Connor R, Geuder KI, et al. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest 1990;62:279-286
11. Kirchner T, Hoppe F, Müller-Hermelink HK, et al. Acetylcholine receptor epitopes on epithelial cells of thymoma in myasthenia gravis. Lancet 1987;1:218 (Letter)
12. Marx A, Wilisch A, Schultz A, et al. Expression of neurofilaments and of a titin epitope in thymic epithelial tumors: implications for the pathogenesis of myasthenia gravis. Am J Pathol 1996;148:1839-1850
13. Nenninger R, Schultz A, Hoffacker V, et al. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Lab Invest 1998;78:743-753
14. Marx A, Kirchner T, Hoppe F, et al. Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis. Am J Pathol 1989;134:865-877
15. Tzartos SJ, Remoundos MS. Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit: dissecting a potentially myasthenogenic epitope. Eur J Biochem 1992;207:915-922
16. Myers MW, Lazzarini RA, Lee VM, et al. The human mid-size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. EMBO J 1987;6:1617-1626
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685
18. Frank R. Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 1992;48:9217-9232
19. Sommer N, Willcox N, Harcourt GC, Newsom Davis J. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann Neurol 1990;28:312-319
20. Sommer N, Harcourt GC, Willcox N, et al. Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology 1991;41:1270-1276
21. Vincent A, Willcox N. Characterization of specific T cells in myasthenia gravis. Immunol Today 1994;15:41-42 (Letter)
22. Willcox N. Myasthenia gravis. Curr Opin Immunol 1993;5: 910-917
23. Wang ZY, Okita DK, Howard J Jr, Conti-Fine BM. Th1 epitope repertoire on the alpha subunit of human muscle acerylcholine receptor in myasthenia gravis. Neurology 1997;48: 1643-1653
24. Nagvekar N, Jacobson LW, Willcox N, Vincent A. Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies. Clin Exp Immunol 1998;112:17-20
25. Hu Q, Bazemore Walker CR, Girao C, et al. Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes. Immunity 1997;7:221-231
26. Sant'Angelo DB, Waterbury PG, Cohen BE, et al. The imprint of intrathymic self-peptides on the mature T cell receptor repertoire. Immunity 1997;7:517-524
27. Ignatowicz L, Kappler J, Marrack P. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 1996;84:521-529
28. Fujii Y, Monden Y, Nakahara K, et al. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma. Neurology 1984;34:1182-1186
29. Kaufman DL, Clare Salzler M, Tian J, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69-72
30. Vincent A, Willcox N, Hill M, et al. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev 1998;164:157-168
31. Nagvekar N, Moody AM, Moss P, et al. A pathogenetic role for the thymoma in myasthenia gravis: autosensitization of IL-4-producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes. J Clin Invest 1998;101:2268-2277
32. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-2492